CN106879749A - 包含dha和epa的有机乳液 - Google Patents

包含dha和epa的有机乳液 Download PDF

Info

Publication number
CN106879749A
CN106879749A CN201710085116.3A CN201710085116A CN106879749A CN 106879749 A CN106879749 A CN 106879749A CN 201710085116 A CN201710085116 A CN 201710085116A CN 106879749 A CN106879749 A CN 106879749A
Authority
CN
China
Prior art keywords
emulsion
dha
tocopherol
acid
gross weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710085116.3A
Other languages
English (en)
Inventor
卡尔·曼弗雷德·沃勒科
丹尼斯·胡戈
托马斯·林德曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Publication of CN106879749A publication Critical patent/CN106879749A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A23D7/0053—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/01—Other fatty acid esters, e.g. phosphatides
    • A23D7/011—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/06—Preservation of finished products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L35/00—Food or foodstuffs not provided for in groups A23L5/00 – A23L33/00; Preparation or treatment thereof
    • A23L35/10—Emulsified foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Edible Oils And Fats (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Cosmetics (AREA)

Abstract

本发明涉及包含DHA和EPA的有机乳液，具体地，包含二十二碳六烯酸(DHA)和二十碳五烯酸(EPA)的油组合物的乳液，其特征在于，该乳液基本上不含抗坏血酸棕榈酸酯。

Description

包含DHA和EPA的有机乳液
本申请是申请日为2013年1月11日的中国专利申请201380005351.5(PCT/EP2013/050447)的分案申请。
本发明涉及包含二十二碳六烯酸(DHA)和二十碳五烯酸(EPA)的油组合物的乳液，其特征在于，该乳液基本上不含抗坏血酸棕榈酸酯。
PUFA油的乳液是已知的。它们可用于多个应用领域，并且它们以液体或干燥形式使用。
PUFA油，即多不饱和脂肪酸，非常易于氧化。由于这一事实，乳液常常包含防止油被氧化的成分。
另一方面，强烈需要提供天然和/或有机的乳液。
在本发明的上下文中，“天然的”和“有机的”与其销售国所设定的法律定义有关。
例如，在欧盟为欧盟生态管理(EU-Eco-regulation)，在美国为国家有机计划标准(National Organic Program(NOP)Standards)，在日本为JAS标准。
本发明的目标是提供包含二十二碳六烯酸(DHA)和二十碳五烯酸(EPA)油的乳液，根据国家规定(特别是欧洲(EU)、美国、日本和中国)其为天然的和/或有机的。
因此，本发明涉及一种乳液，其包含：
基于乳液的总重，5-40重量-％(wt-％)的二十二碳六烯酸(DHA)和二十碳五烯酸(EPA)油；和
基于乳液的总重，3-15wt-％的至少一种乳化剂；和
基于乳液的总重，1-5wt-％的抗坏血酸和/或柠檬酸；
基于乳液的总重，0.5-5wt-％的至少一种碱；和
基于乳液的总重，35-90.5wt-％的水；和
150ppm-1000ppm的至少一种生育酚；和
1000ppm-5000ppm的迷迭香提取物，
其中，
该乳液的pH介于5和7之间；并且
该乳液基本上不含抗坏血酸棕榈酸酯；并且
该乳液是天然的和/或有机的。
在本发明的上下文中，“基本上不含抗坏血酸棕榈酸酯(AP)”指的是，根据“有机”和“天然”的法律定义，根据本发明的乳液仍可视为“有机的”和/或“天然的”。
根据本发明的所有成分都是天然和/或有机的。这表示，该乳液的所有成分都是通过使用天然和/或有机的方法来生产(或提取)的。
DHA和EPA油可以来自任意天然和/或有机源，例如植物和/或动物。ω-3脂肪酸(例如DHA)的一种来源包括动物源。动物源的实例包括水生动物(例如鱼、海洋哺乳动物和甲壳类动物，如磷虾和其它磷虾目动物)和动物组织(例如脑、肝、眼等)、和动物产品(例如蛋或乳)。
DHA和EPA可以纯化至不同程度。所述纯化可以通过本领域技术人员已知的任何方式来实现。在本发明的上下文中，纯化必须使得经纯化的油是天然和/或有机的。
油中可以存在额外的脂肪酸。这些脂肪酸可以包括在纯化过程中未被除去的脂肪酸，也就是，从原料中与DHA和EPA一起共分离的脂肪酸。这些脂肪酸可以以各种浓度存在。在一些实施方式中，所述油包含0.1％至60％的的一种或多种下列脂肪酸或其酯：(a)癸酸；(b)月桂酸；(c)肉豆蔻酸；(d)棕榈酸；e)棕榈油酸；(f)硬脂酸；(g)油酸；(h)亚油酸；(i)α-亚油酸；(j)二十二碳五烯酸22：5n-3，22：5w3(DPAn3)；和(k)4，7，10，13，16，19，22，25-二十八碳八烯酸(C28：8)。所有这些油也符合天然和/或有机的标准。
根据本发明的乳液中使用的乳化剂也是天然和/或有机的。这样的乳化剂可以是任何来源的。用于根据本发明的乳液的合适乳化剂是卵磷脂、乳清蛋白、阿拉伯树胶(水提取的)、水解的骨胶原、果胶和鱼明胶(fish gelatine)。特别优选的是鱼明胶。
抗坏血酸以及柠檬酸是天然和/或有机的。通常它们来自植物。
根据本发明的乳液中使用的碱可以是(在化学上)有机或无机的。但该碱必须始终符合如上所述的法律术语“有机”的标准。特别优选的碱是NaOH。
术语“生育酚”指的是dl-α-生育酚、d-□-生育酚、β-生育酚、□.生育酚和□-生育酚及其混合物，而根据本发明的乳液中使用的生育酚是天然和/或有机的。
在一些实施方式中，生育酚以150ppm到1000ppm的量存在于乳液中，在一个优选的实施方式中，生育酚以200到800ppm的量存在。
生育酚(或生育酚的混合物)可以混入乳液中，或者其可以先混入PUFA油中，然后作为混合物添加到乳液中。
根据本发明的乳液包含迷迭香提取物。
短语“迷迭香提取物”指的是能从迷迭香得到的、具有抗氧化活性的任意提取物。提取以能得到天然和/或有机迷迭香提取物的方式进行。
迷迭香(Rosmarinus officinalis，唇形科)是一种在地中海地区无处不在的织物，其特征是抗氧化和抗菌的药理性质。
迷迭香提取物是从迷迭香植物中提取的天然和已知的材料。
迷迭香提取物可以通过如下获得：干燥迷迭香(属于紫苏科)的叶子、粉碎经干燥的叶子、以及使所产生的粉碎物经历(用水、热水、己烷、乙醇、丙酮、乙酸乙酯、或这些溶剂的混合物)萃取。在本文中使用时，术语“迷迭香提取物”是一个通用术语，描述了一些可能包含多种不同活性成分的不同化学组合物。其中在迷迭香提取物中发现的常见的组分有：咖啡酸；鼠尾草酚；鼠尾草酸；甲氧基鼠尾草酸；迷迭香酸；迷迭香酚；和迷迭香二酚；所有这些组分可以以不同的比例存在，这取决于单个提取物。众多的迷迭香提取物也可以商购，并且任何一种或多种可以在本发明中使用。
合适的迷迭香提取物是商购自例如Kalsec(Kalamazoo，M1，USA)或Naturex(Avignon，France)公司的那些。
根据本发明的乳液包含1000ppm-5000ppm的迷迭香提取物，优选500ppm到4000ppm，更优选500到3500ppm。
此外，本发明涉及一种用于生产根据本发明的乳液的方法，其中所有成分以及工艺步骤都是天然和/或有机的。
根据本发明的乳液可用于其中需要该乳液的任何应用。
该乳液可用于例如食物、饲料或个人护理产品。
这些产品可以为任何形式，例如液体、凝胶状或固体。这些产品可以是随时可使用(随时可消费)的产品、以及需要进一步加工(例如通过稀释、溶解，加热等)的产品。
特别重要的是这些乳液是在食品(如饮料)中的用途。
下列实施例说明本发明。如上所述感官值和rancimat值是确定了的。
实施例
成分 量[wt-％]
EPA 4.8
DHA 3
鱼明胶 8.0
抗坏血酸 2.2
NaOH(50％的水溶液) 1.0
水含量(总计) 62.8
其它油 18.2
通过下列方法制备乳液：分别制备油相和水相，随后通过适当的预均化装置(例如转子-定子、micer圆盘等)将油相在水相中均质化，并且随后施加高压均质。
该乳液的pH值为6。
该天然和有机的乳液储存稳定并且易于掺入任意制剂。

Claims (10)

1.一种乳液，其包含：
基于所述乳液的总重，5-40wt-％的二十二碳六烯酸(DHA)和二十碳五烯酸(EPA)油；和
基于所述乳液的总重，3-15wt-％的至少一种乳化剂；和
基于所述乳液的总重，1-5wt-％的抗坏血酸和/或柠檬酸；
基于所述乳液的总重，0.5-5wt-％的至少一种碱；和
基于所述乳液的总重，35-90.5wt-％的水；和
150ppm-1000ppm的至少一种生育酚；和
1000ppm-5000ppm的迷迭香提取物，
其中，
所述乳液的pH介于5和7之间；并且
所述乳液基本上不含抗坏血酸棕榈酸酯。
2.如权利要求1所述的乳液，其中，所述乳液是天然和/或有机的。
3.如前面任何一个权利要求所述的乳液，其中，所述乳化剂选自由卵磷脂、乳清蛋白、阿拉伯树胶(水提取的)、水解的骨胶原、果胶和鱼明胶组成的组。
4.如前面任何一个权利要求所述的乳液，其中，所述乳化剂是鱼明胶。
5.如前面任何一个权利要求所述的乳液，其中，所用的碱是NaOH。
6.如前面任何一个权利要求所述的乳液，其中，所述生育酚选自由dl-α-生育酚、d-α-生育酚、β-生育酚、γ-生育酚和δ-生育酚组成的组。
7.如前面任何一个权利要求所述的乳液，其中，使用200到800ppm的生育酚。
8.如前面任何一个权利要求所述的乳液，其中，使用500到4000ppm的迷迭香提取物。
9.权利要求1-8中任意一项所述的乳液在食物、饲料或个人护理产品中的用途。
10.包含权利要求1-8中任意一项所述乳液的食物、饲料或个人护理产品。
CN201710085116.3A 2012-01-11 2013-01-11 包含dha和epa的有机乳液 Pending CN106879749A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12150757.8 2012-01-11
EP12150757 2012-01-11
CN201380005351.5A CN104039159A (zh) 2012-01-11 2013-01-11 包含dha和epa的有机乳液

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201380005351.5A Division CN104039159A (zh) 2012-01-11 2013-01-11 包含dha和epa的有机乳液

Publications (1)

Publication Number Publication Date
CN106879749A true CN106879749A (zh) 2017-06-23

Family

ID=47598792

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201710085116.3A Pending CN106879749A (zh) 2012-01-11 2013-01-11 包含dha和epa的有机乳液
CN201380005351.5A Pending CN104039159A (zh) 2012-01-11 2013-01-11 包含dha和epa的有机乳液

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201380005351.5A Pending CN104039159A (zh) 2012-01-11 2013-01-11 包含dha和epa的有机乳液

Country Status (11)

Country Link
US (1) US9579301B2 (zh)
EP (1) EP2802217A1 (zh)
JP (1) JP2015506175A (zh)
KR (1) KR20140116482A (zh)
CN (2) CN106879749A (zh)
AU (1) AU2013208915B2 (zh)
BR (1) BR112014017048A8 (zh)
IN (1) IN2014DN05811A (zh)
MX (1) MX349987B (zh)
NZ (1) NZ627354A (zh)
WO (1) WO2013104740A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115697088A (zh) * 2020-05-02 2023-02-03 鲍斯生命科学Pvt有限公司 富含ω脂肪酸的油分散制剂

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105231333A (zh) * 2015-11-12 2016-01-13 东北农业大学 一种dha营养乳液的制备方法
KR101854018B1 (ko) 2015-12-23 2018-05-02 주식회사 다인소재 항산화 활성을 갖는 초음파분산 나노 에멀젼 형태의 조성물
BR112020024464A2 (pt) * 2018-06-14 2021-03-02 Mars, Incorporated composição de suporte para animal com câncer
KR102151022B1 (ko) * 2019-08-29 2020-09-02 유씨엘 주식회사 로즈마리로부터 카페인산과 로즈마린산을 추출하는 방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101472485A (zh) * 2006-04-07 2009-07-01 加拿大海洋营养食品有限公司 含有具有低界面张力的物质的乳状液和微胶囊、其制备及使用的方法
CN102041169A (zh) * 2010-12-23 2011-05-04 厦门金达威集团股份有限公司 一种适用于不饱和脂肪酸及其酯的抗氧化剂组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007120500A2 (en) * 2006-04-07 2007-10-25 Ocean Nutrition Canada Ltd. Emulsions and microcapsules with substances having low interfacial tension, methods of making and using thereof
DE102009023482A1 (de) * 2009-06-02 2010-12-09 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Emulsion oder Gel zur Herstellung von Omega-3-Fettsäure-haltigen Nahrungsmitteln
CN102939079B (zh) * 2010-04-09 2016-01-06 帝斯曼知识产权资产管理有限公司 包含含有多不饱和脂肪酸的油的热稳定的水包油乳液

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101472485A (zh) * 2006-04-07 2009-07-01 加拿大海洋营养食品有限公司 含有具有低界面张力的物质的乳状液和微胶囊、其制备及使用的方法
CN102041169A (zh) * 2010-12-23 2011-05-04 厦门金达威集团股份有限公司 一种适用于不饱和脂肪酸及其酯的抗氧化剂组合物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FRANKEL, E. N., HUANG, S.-W., PRIOR, E., & AESCHBACH, R.: "Evaluation of Antioxidant Activity of Rosemary Extracts, Carnosol and Carnosic Acid in Bulk Vegetable Oils and Fish Oil and Their Emulsions.", 《JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE》 *
SURH, J., DECKER, E., & MCCLEMENTS, D.: "Properties and stability of oil-in-water emulsions stabilized by fish gelatin.", 《FOOD HYDROCOLLOIDS》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115697088A (zh) * 2020-05-02 2023-02-03 鲍斯生命科学Pvt有限公司 富含ω脂肪酸的油分散制剂

Also Published As

Publication number Publication date
NZ627354A (en) 2016-07-29
MX2014008494A (es) 2014-10-14
BR112014017048A8 (pt) 2017-07-04
IN2014DN05811A (zh) 2015-05-15
KR20140116482A (ko) 2014-10-02
AU2013208915B2 (en) 2016-03-17
CN104039159A (zh) 2014-09-10
US20140356464A1 (en) 2014-12-04
US9579301B2 (en) 2017-02-28
AU2013208915A1 (en) 2014-07-31
MX349987B (es) 2017-08-22
JP2015506175A (ja) 2015-03-02
BR112014017048A2 (pt) 2017-06-13
WO2013104740A1 (en) 2013-07-18
EP2802217A1 (en) 2014-11-19

Similar Documents

Publication Publication Date Title
Echegaray et al. Chestnuts and by-products as source of natural antioxidants in meat and meat products: A review
Serra et al. Dietary polyphenol supplementation in food producing animals: Effects on the quality of derived products
Wang et al. Effects of a natural antioxidant, polyphenol-rich rosemary (Rosmarinus officinalis L.) extract, on lipid stability of plant-derived omega-3 fatty-acid rich oil
Semwogerere et al. Bioavailability and bioefficacy of hemp by-products in ruminant meat production and preservation: A review
Karami et al. The effect of palm oil or canola oil on feedlot performance, plasma and tissue fatty acid profile and meat quality in goats
CN106879749A (zh) 包含dha和epa的有机乳液
Petcu et al. Effects of plant-based antioxidants in animal diets and meat products: A review
Rostamzad et al. Antioxidative activity of citric and ascorbic acids and their preventive effect on lipid oxidation in frozen Persian sturgeon fillets
Álvarez-Rodríguez et al. Insights into the role of major bioactive dietary nutrients in lamb meat quality: A review
Sadighara et al. Antioxidant activity and properties of walnut brown seed coat extract
CN106173194A (zh) 一种动物饲料用生物性抗氧化剂
EP2437615B1 (de) Emulsion oder gel zur herstellung von omega-3-fettsäure-haltigen nahrungsmitteln
Ghanima et al. Impacts of nano-emulsified vegetable oil on growth, hemato-biochemical markers, oxidative stress, and gut microbiota of New Zealand white and V-line rabbits
Hosseini-Vashan et al. Effects of turmeric rhizome powder and source of oil in diet on blood metabolites, immune system and antioxidant status in heat stressed broiler chickens
Mohammadi et al. Effects of dietary supplementation of date palm (Phoenix dactylifera) seed extract on body composition, lipid peroxidation and tissue quality of common carp (Cyprinus carpio) juveniles based on the total volatile nitrogen test
EP3920721A1 (en) Antioxidant composition comprising quercetagetin and gallic acid
WO2009150179A2 (en) Plant extract and pufa combinations
Rahman et al. Influence of onion (Allium cepa L.) supplementation on physio-chemical composition and lipid profile of broiler meat
CN106173195A (zh) 一种动物饲料用生物性抗氧化剂的制备方法
JPH02290812A (ja) 抗アレルギー性油脂組成物
Hamada et al. Meat safety and quality of broiler chickens supplemented with thyme essential oil.
Khalati et al. Hematological parameters and relative weight of some organs for broiler chickens supplemented by different levels of nano propolis
Pinedo-Gil et al. Effect of red beet and betaine modulating oxidation and bioactivity of rainbow trout
Al-Farnwany et al. Modulation of Antioxidant Activities in Japanese Quails Using Graded Levels of Rosemary Oil Supplemented Diet.
Tajudeen et al. Influence of Sophora koreensis on the meat quality and growth performance of Korean native chickens.

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170623

WD01 Invention patent application deemed withdrawn after publication